Elicio Therapeutics, Inc.
ELTX
$11.68
-$0.50-4.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.72M | -10.08M | -10.56M | -11.21M | -14.00M |
| Total Depreciation and Amortization | 286.00K | 283.00K | 281.00K | 278.00K | 305.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -804.00K | 2.89M | 1.68M | 1.17M | 1.27M |
| Change in Net Operating Assets | 1.44M | -4.18M | -351.00K | -354.00K | 3.69M |
| Cash from Operations | -6.80M | -11.09M | -8.95M | -10.12M | -8.74M |
| Capital Expenditure | -16.00K | -- | -- | -- | -45.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.00K | -- | -- | -- | -45.00K |
| Total Debt Issued | 0.00 | 0.00 | 9.87M | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.86M | 9.57M | 2.07M | 10.33M | 227.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 4.86M | 9.57M | 11.93M | 10.33M | 227.00K |
| Foreign Exchange rate Adjustments | -96.00K | 39.00K | 74.00K | 31.00K | 27.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.05M | -1.48M | 3.06M | 240.00K | -8.54M |